These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 21860103)

  • 1. Drug resistance in malaria.
    Parija SC; Praharaj I
    Indian J Med Microbiol; 2011; 29(3):243-8. PubMed ID: 21860103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium vinckei: selection of a strain exhibiting stable resistance to arteether.
    Puri SK; Chandra R
    Exp Parasitol; 2006 Oct; 114(2):129-32. PubMed ID: 16624307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the in vivo tolerance and in vitro reduced susceptibility to the antimalarial lumefantrine.
    Nzila A; Okombo J; Ohuma E; Al-Thukair A
    J Antimicrob Chemother; 2012 Oct; 67(10):2309-15. PubMed ID: 22761327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The origins of antimalarial drug resistance.
    Hastings IM
    Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
    O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
    Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
    Schlitzer M
    ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malaria and drug resistance].
    Kager PA; Wetsteyn JC
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):151-5. PubMed ID: 8618636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel molecular targets for antimalarial drug development.
    Sahu NK; Sahu S; Kohli DV
    Chem Biol Drug Des; 2008 Apr; 71(4):287-97. PubMed ID: 18298458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance hampers our capacity to roll back malaria.
    Olliaro P
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S247-57. PubMed ID: 16032560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant malaria: molecular mechanisms and implications for public health.
    Petersen I; Eastman R; Lanzer M
    FEBS Lett; 2011 Jun; 585(11):1551-62. PubMed ID: 21530510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malarial protease inhibitors: potential new chemotherapeutic agents.
    Sharma A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):642-52. PubMed ID: 17668366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of some medicinal plants traditionally used for treatment of malaria in Kenya as potential sources of antimalarial drugs.
    Muthaura CN; Keriko JM; Derese S; Yenesew A; Rukunga GM
    Exp Parasitol; 2011 Mar; 127(3):609-26. PubMed ID: 21095187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets.
    Ding XC; Beck HP; Raso G
    Trends Parasitol; 2011 Feb; 27(2):73-81. PubMed ID: 21169061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal assay design for determining the in vitro sensitivity of ring stage Plasmodium falciparum to artemisinins.
    Xie SC; Dogovski C; Kenny S; Tilley L; Klonis N
    Int J Parasitol; 2014 Oct; 44(12):893-9. PubMed ID: 25161101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.
    Tang YQ; Ye Q; Huang H; Zheng WY
    Curr Mol Med; 2020; 20(8):583-592. PubMed ID: 32031068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.